Mechanism of stone formation

Seminars in Nephrology

Volumn 16, Issue 5, 1996, Pages 364-374

  Mandel, Neil ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOSITION; CRYSTALLIZATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STONE FORMATION; UROLITHIASIS;

CRYSTALLIZATION; HUMANS; URINARY CALCULI;

EID: 0029761042     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Prien EL: Studies in urolithiasis: II. Relationships between pathogenesis, structure, and composition and calculi. J Urol 61:821-836, 1949
2. Herring LC: Observations on the analysis of ten thousand urinary calculi. J Urol 88:545-562, 1962
3. Lonsdale K, Sutor DJ, Wooley S: Composition of urinary calculi by x-ray diffraction. Collected data from various localities. I. Norwich (England) and district, 1773-1961. Br J Urol 40:33-36, 1968
4. Sutor DJ, Wooley SE: Composition of urinary calculi by x-ray diffraction: Collected data from various localities. IX. Glasgow, Scotland. Br J Urol 43:268-272, 1971
5. Bastian HP, Gebhardt M: Die harnsteinanalyse. Therapiewoche 26:5935-5938, 1976
6. Brien G, Schubert G, Bick C: 10,000 analyses of urinary calculi using x-ray diffraction and polarizing microscopy. Eur Urol 8:251-256, 1982
7. Mandel NS, Mandel GS: Urinary tract stone disease in the United States Veteran population: II. Geographical variation in composition. J Urol 142:1516-1521, 1989
8. Sutor DJ: Difficulties in the identification of components of mixed urinary calculi using the x-ray powder method. Br J Urol 40:29-32, 1968
9. Pak CYC: Physicochemical basis for formation of calcium phosphate origin: Calculation of the degree of saturation of urine with respect to brushite. J Clin Invest 48:1914-1922, 1969
10. Robertson WG, Peacock M, Nordin BEC: Activity products in stone-forming and non-stone-forming urine. Clin Sci 34:579-594, 1968
11. Finalyson B, Roth R, DuBois L: Calcium oxalate solubility studies, in Smith L (ed): Urinary Calculi: International Symposium on Renal Stone Research. Madrid, Spain, 1972, pp 1-7
12. Werness PG, Brown CM, Smith LH, et al: EQUIL2: A basic computer program for the calculation of urinary saturation. J Urol 134:1242-1244, 1985
13. Mandel NS, Mandel GS: Structures of crystals that provoke inflammation, in Weissmann G (ed): Advances in Inflammation Research, vol 4. New York, NY, Raven Press, 1982, pp 73-94
14. Brown CM, Purich DL: Physical-chemical processes in kidney stone formation, in Coe FL, Favus MJ (eds): Disorders of Bone and Mineral Metabolism, ed 1. New York, NY, Raven Press, 1992, pp 613-624
15. Finalyson B: Physicochemical aspects of urolithiasis. Kidney Int 13:344-360, 1978
16. Hess B, Kok DJ: Nucleation, growth, and aggregation of stone-forming crystals, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 3-32
17. Garten VA, Head RB: Homogeneous nucleation and phenomenon of crystallo-luminescence. Phil Mag 14:1243, 1966
18. Boyce W, Garvey FK: The amount and nature of the organic matrix in urinary calculi: A Review. J Urol 76:213, 1956
19. Boyce WH: Organic matrix of human urinary concretions. Am J Med 45, 673, 1956
20. Khan SR, Shevock PN, Hackett RL: In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of urinary stones. J Urol 139:418, 1988
21. Khan SR, Shevock PN, Hackett RL: Presence of lipids in urinary stones: Results of preliminary studies. Calcif Tissue Int 42:91, 1988
22. Kim KM: Lipid matrix of dystrophic calcification and urinary stone. Electron Microscopy 3:1275, 1983
23. Warpehoski MA, Buscemi PJ, Osborn DC, et al: Distribution of organic matrix in calcium oxalate renal calcuii. Calcif Tissue Int 33:211, 1981
24. Khan SR, Hackett RL: Role of organic matrix in urinary stone formation: An ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. J Urol 150:239, 1993
25. Carr JA: The pathology of urinary calculi: radial striation. Br J Urol 25:26, 1953
26. Khan SR, Hackett RL: Crystal-matrix relationships in experimentally induced calcium oxalate monohydrate crystals: An ultrastructural study. Calcif Tissue Int 41:157, 1987
27. Khan SR, Finlayson B, Hackett RL: Stone matrix as proteins adsorbed on crystal surfaces: A microscopic study. Scanning Microscopy 1:379, 1983
28. Khan SR, Hackett RL: Microstructure of decalcified human calcium oxalate urinary stones. Scanning Electron Microscopy 2:935, 1984
29. Khan SR, Hackett RL, Finlayson B: Morphology of urinary stone particles resulting from ESWL treatment. J Urol 136:1367, 1986
30. Shiba KS, Kanamon K, Cho H, et al: Re-evaluation of normal urinary proteins fractionated by one dimensional sodium-dodecyl sulphate polyacrylamide electrophoresis. Clin Chim Acta 172:77, 1988
31. Nishio S, Abe Y, Wakatsuki A, et al: Matrix glycosaminoglycans in urinary stones. J Urol 134:503, 1985
32. Nakagawa Y, Ahmed MA, Hall SL, et al: Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. J Clin Invest 79:1782, 1987
33. Lian JB, Prien EL Jr, Glimcher MJ, et al: The presence of protein-bound γ-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest 59:1151, 1977
34. Doyle IR, Ryall RL, Marshall VR: Inclusion of proteins into calcium oxalate crystal precipitated from human urine: A highly selective phenomenon. Clin Chem 37:1589, 1991
35. Shiraga H, Min W, VanDusen WJ, et al: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426, 1992
36. Hoyer JR: Uropontin in urinary calcium stone formation. Miner Electrolyte Metab 20:385-392, 1994
37. Atmani F, Lacour B, Dtueke T, et al: Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization. Urol Res 21:61, 1993
38. Ryall RL, Stapleton AMF: Urinary macromolecules in calcium oxalate stone and crystal matrix: Good, bad, or indifferent, in Khan SR (ed): Calcium Oxalate in Biological Systems. Boca Raton, FL, CRC Press, 1995, pp 265-290
39. Tamm I, Horsfall FL: Characterisation and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 74:108, 1950
40. Sikn KL, Foster CL, MacHugh N, et al: Localization of Tamm-Horsfall glycoprotein in the human kidney using immuno-florescence and immuno-electron microscopical techniques. J Anat 132:597, 1981
41. Peach RJ, Day WA, Ellingson PJ, et al: Ultrastructural localization of Tamm-Horsfall protein in human kidney using immunogold electron microscopy. Histochem J 20:156, 1988
42. Hunt JS, McGiven AR, Grouvsky A, et al: Affinity-purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall glycoprotein in urine. Biochem J 227:957, 1994
43. Muchmore AV, Decker JM: Uromodulin: A unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science 229:479, 1985
44. Stevenson FK, Cleave AJ, Kent PW: The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein. Biochem Biophys Acta 236:59, 1971
45. Pesce AJ, Kant KS, Clyne DH, et al: A model of urinary cast formation. Clin Chem 23:1146, 1977 (abstr)
46. Curtain CC: The action of urea on the urinary inhibitor of influenza virus hemagglutination. Aust J Exp Biol 31:615, 1953
47. Ryall RL, Harnett RM, Hibberd CM, et al: Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol Res 19:181, 1991
48. Grover PK, Ryall RL, Marshall VR: Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine? Clin Chim Acta 190:223, 1990
49. Hallson PC, Rose GA: Uromucoids and urinary stone formation. Lancet 1:1000, 1979
50. Rose GA, Sulaiman S: Tamm-Horsfall mucoprotein promotes calcium oxalate crystal formation in urine: Quantitative studies. J Urol 127:177, 1982
51. Yoshioka T, Koide T, Utsunomiya M: Possible role of Tamm-Horsfall glycoprotein in calcium oxalate crystallization. Urology 64:463, 1989
52. Nakagawa Y, Kaiser ET, Coe FL: Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine. Biochem Biophys Res Commun 84:1038, 1978
53. Nakagawa Y, Margolis HC, Yokoyama S, et al: Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem 256:3936, 1981
54. Nakagawa Y, Abram V, Kezdy FJ, et al: Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594, 1983
55. Nakagawa Y, Abram V, Coe FL: Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine. Am J Physiol 247:F765, 1984
56. Nakagawa Y, Parks JH, Kezdy FJ, et al: Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Phys 98:281, 1985
57. Nakagawa Y, Abram V, Parks JH, et al: Urine glycoprotein crystal growth inhibitors: Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest 76:1455, 1985
58. Coe FL, Margolis LH, Deutsch LH, et al: Urinary macromolecular crystal growth inhibitors in calcium nephrolithiasis. Miner Electrolyte Metab 3:268, 1980
59. Netzer M, Nakagawa Y, Coe FL: Charactetization of a new antibody to nephrocalcin (NC), a major urinary inhibitor of calcium oxalate monohydrate (COM) crystal growth. Kidney Int 37:474, 1990 (abstr)
60. Nakagawa Y, Netzer M, Coe FL: Immunohistochemical localization of nephrocalcin (NC) to proximal tubule and thick ascending limb of Henle's loop (TALH) of human and mouse kidney: Resolution of a conflict. Kidney Int 37:474, 1990 (abstract)
61. Nakagawa Y, Sirivongs D, Novy MB, et al: Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res 52:1573, 1992
62. Kaiser ET, Bock SC: Protein inhibitors of crystal growth. J Urol 141:750, 1989
63. Hess B, Nakagawa Y, Coe FL: Nephrocalcin isolated from human kidney stones is a defective calcium oxalate monohydrate crystal aggregation inhibitor, in Walker VR, Sutton RAL, Cameron EC, et al (eds): Urolithiasis. New York, NY, Plenum, 1989, 137
64. Tang Y, Graver PK, Moritz RL, et al: Is nephrocalcin related to the urinary derivative (bikunin) of inter-α-trypsin inhibitor? Br J Urol 76:425-430, 1995
65. Hoyer JR: Osteopontin in urinary calcium stone formation. Ann NY Acad Sci 760:257-265, 1995
66. Atmani F, Lacour B, Strecker G, et al: Molecular characteristics of uronic-acid-rich protein, a strong inhibitor of calcium oxalate crystallization in vitro. Biochem Biophys Res Commun 191:158, 1993
67. Atmani F, Lacour B, Jungers P: Reduced inhibitory activity of uronic-acid-rich protein (UAP) in the urine of stone formers. Urol Res 22:257, 1994
68. Stapleton AMF, Ryall RL: Crystal matrix protein - Getting blood out of a stone. Miner Electrolyte Metab (in press)
69. Stapleton AMF, Seymour AE, Brennan JS, et al: Immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int 44:817, 1993
70. Ryall RL, Grover PK, Stapleton AMF, et al: The urinary Fl activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci 89:533-541, 1995
71. Welshman SG, McGeown MG: Urinary citrate excretion in stone formers and normal controls. Br J Urol 48:7-11, 1972
72. Fleisch H, Bisaz S: The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis. Experientia 20:276, 1964
73. Moore CA, Bunce GE: Reduction in frequency of renal calculus formation by oral magnesium administration. Invest Urol 2:7-13, 1964
74. Elliot JS, Ribeiro ME: The urinary excretion of trace metals in patients with calcium oxalate urinary stones. Invest Urol 10:253-255, 1973
75. Finlayson B: Symposium on Renal Lithiasis. Renal Lithiasis in Review. Urol Clin North Am 1:181-212, 1974
76. Lonsdale K: Epitaxy as a growth factor in urinary calculi and gallstones. Nature 217:56-58, 1968
77. Mandel NS, Mandel GS: Epitaxis between stone forming crystals at the atomic level, in Coe FL, Brenner BM, Stein JH (eds): Contemporary Issues in Nephrology. New York, NY, Churchill Livingstone, 1980, pp 37-58
78. Mandel NS, Mandel GS: Epitaxis between stone forming crystals at the atomic level, in Smith LH, Robertson WG, Finlayson B (eds): Urolithiasis: Clinical and Basic Research. New York, NY, Plenum Press, 1981, pp 469-480
79. Meyer JL, Bergert JH, Smith LH: Epitaxial relationships in urolithiasis: The calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med 49:369-374, 1975
80. Meyer JL, Bergert JH, Smith LH: The epitaxial induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol 14:115-121, 1976
81. Meyer JL, Bergert JH, Smith LH: Epitaxial relationships in urolithiasis: The brushite-whewellite system. Clin Sci Mol Med 52:143-148, 1977
82. Coe FL, Kavalach AG: Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 291:1344-1350, 1974
83. Coe FL, Strauss AL, Tembe V, et al: Uric acid saturation in calcium nephrolithiasis. Kidney Int 17:662-668, 1980
84. Pak CYC, Waters O, Arnold LR, et al: Mechanism for calcium urolithiasis among patients with hyperuricosuria. J Clin Invest 59:426-431, 1977
85. Randall A: The origin and growth of renal calculi. Ann Surg 105:1009-1027, 1937
86. Randall A: Papillary pathology and precursor of primary renal calculi. J Urol 44:580-589, 1940
87. Carr RJ: A new theory on the formation of renal calculi. Br J Urol 26:105-114, 1953
88. Finlayson B, Reid F: The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442-448, 1978
89. Burns JR, Finlayson B, Gauthier J: Calcium oxalate retention in subjects with crystalluria, in Ryall RL, Brockris JG, Marshall VR, et al (eds): Urinary Stones New York, NY, Churchill Livingstone, 1984, pp 253-257
90. Morgenroth K, Bachmann R, Blaschke R: Uber die formen der calciumoxalata blagerungen und der menschlichen niere bei oxalase. Beitr Pathol Anat 136:454-463, 1968
91. Farebrother DA, Pincott JR, Simmons HA, et al: Uric acid crystal-induced nephropathy: Evidence for a specific renal lesion in a gouty family. J Pathol 135:59-168, 1981
92. Khan SR, Finlayson B, Hackett RL: Histologic study of early events in oxalate induced intranephronic calculosis. Invest Urol 17:199-202, 1979
93. Khan SR, Finlayson B, Hackett RL: Scanning electron microscopy of calcium oxalate crystal formation in experimental nephrolithiasis. Lab Invest 41:504-510, 1979
94. Khan SR, Finlayson B, Hackett RL: Experimental calcium oxalate nephrolithiasis. Role of the renal papilla. Am J Pathol 107:59-69, 1982
95. Rushton HG, Spector M: Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol 12:598-604, 1982
96. Delatte LC, Minon-Cifuentes, Medina JA: New studies on papillary calculi. J Urol 1024-1029, 1987
97. Gill WB, Ruggiero K, Straus FH: Crystallization studies in a urothelial-lined living test tube (the catheterized female rat bladder): I. Calcium oxalate crystal adhesion to the chemically injured rat bladder. Invest Urol 17:257-261, 1979
98. Khan SR, Hackett RL: Renal proximal tubular injury and crystallization of calcium oxalate in rat urine, in Sutton RAL, Cameron EC, Walker V, et al (eds): Urolithiasis. New York, NY, Plenum, 1989, pp 117-119
99. Khan SR, Hackett RL: Calcium oxalate urolithiasis in the rat: Is it a model for human stone disease? A review of recent literature. Scanning EM II: 759-774, 1985
100. Menon M, Strzelecki T, Laxmanan S, et al: Histological and biochemical characterization of a model of nephrolithiasis incorporating proximal tubular dysfunction, in Sutton RAL, Cameron EC, Walker V, et al (eds): Urolithiasis. New York, NY, Plenum, 1989, pp 329-331
101. 1) cells in culture. J Pharmacol Exp Ther 236:254-262, 1986
102. Wiessner JH, Kleinman J, Blumenthal S, et al: Calcium oxalate crystal interaction with rat renal inner papillary collecting tubule cells. J Urol 138:640-643, 1987
103. Riese RJ, Riese JW, Kleinman JG, et al: Specificity in calcium oxalate adherence to papillary epithelial cells in culture. Am J Physiol 255:F1025-F1032, 1988
104. Riese RJ, Wiessner JH, Mandel GS, et al: Binding of calcium oxalate and apatite crystals to renal papillary collecting tubule cells in primary culture, in Sutton RAL, Cameron EC, Walker V, et al (eds): Urolithiasis. New York, NY, Plenum, 1989, pp 75-78
105. Riese RJ, Kleinman JG, Wiessner JH, et al: Uric acid crystal binding to renal inner medullary collecting duct cells in primary culture. J Am Soc Nephrol 1:182-192, 1990